Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |